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Abstract In addition to the three alleles commonly responsible 
for the protein polymorphism of human deoxyribonuclease I, a 
mutation encoded by a fourth allele, DNASEI*4, was detected 
by isoelectric focusing. All 8 exons covering the entire open read- 
ing frame of the human DNase I gene were amplified by the 
polymerase chain reaction and subjected to direct sequencing. 
Only one nucleotide substitution, a C-to-G transition (CAG--~ 
GAG), in the codon for amino acid 9 of the mature enzyme was 
found. This substitution resulted in the replacement of Gin with 
Gin (Q9E). 
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1. Introduction 
Deoxyribonuclease I (DNase I; EC 3.1.21.1) has been postu- 
lated to be responsible for internucleosomal DNA degradation 
during apoptosis (programmed cell death) [1,2]. Genetic poly- 
morphism of human DNase I has been demonstrated by isoen- 
zyme pattern differences detectable by isoelectric focusing [3]. 
The discovery that DNase I activity is distributed in human 
tissues other than those of the digestive system [4,5] may indi- 
cate further in vivo function(s) of DNase I. 
The structural gene encoding human DNase I has been se- 
quenced and found to comprise 9 exons spanning approxi- 
mately 3.2 kilobases [6]. Three common alleles, DNASEI*I, *2 
and *3, the gene frequencies of which have been determined to 
be about 0.55, 0.44 and 0.01, respectively, occur in the Japanese 
population [7]. The protein polymorphism of DNase I has been 
found to be caused by an A-to-G transition (CAA ~ CGA) at 
nucleotide position 2317 in exon VIII, forming the second al- 
lele, and a C-to-G transversion (CCC--* GCC) at position 1592 
in exon VI forming the third allele. These changes are respon- 
sible for replacement of Gin by Arg at amino acid position 222 
(Q222R) and of Pro by Ala at position 132 (P132A) of the 
mature enzyme, respectively, resulting in the different electro- 
phoretic mobilities of each phenotype [6,8]. A rare fourth allele, 
DNASEI*4, has been observed at a mutational evel (gene 
frequency of  less than 0.01) [2,7]. However, the molecular basis 
of the fourth allele remains to be demonstrated. 
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In this study, we describe the molecular analysis of the fourth 
allele, using direct DNA sequencing of the specific products 
amplified by the polymerase chain reaction (PCR). We also 
present he mutation screening method which is based on mis- 
matched PCR. 
2. Materials and methods 
2.1. Analysis of DNase I protein polymorphism 
Urine samples, obtained from healthy Japanese individuals, were 
concentrated, dialyzed and finally freeze-dried, as described previously 
[9,10]. A 0.1% (w/v) solution of the freeze-dried material, corresponding 
to about 10-fold concentrated urine, was used for DNase I phenotyp- 
ing. Each urine solution was treated with an equal volume of 5 U/ml 
Clostridium perfringens sialidase (Sigma, St. Louis, MO), then 5 pl 
digest was subjected to isoelectric focusing in a thin layer of poly- 
acrylamide gel (IEF-PAGE) and the isoenzyme patterns of DNase I 
were detected by immunostaining with an anti-urinary DNase I anti- 
body [9,11]. The enzymatic activity of serum DNase I was measured by 
the single radial enzyme diffusion method [3]. 
2.2. Primer construction 
Primers for amplification and sequencing were constructed using the 
DNA sequence of the human DNase I gene as a base [6], as shown in 
Fig. 1. Each primer corresponded to one of the following regions of the 
DNase I genomic sequence, and the numbering system for the se- 
quences was as described previously [6]: U1 (-355 to -336), D1 (185- 
204), U2 (408-427), D2 (861-880), U3 (1149-1168), D3 (1383-1402), 
U4 (1434-1463), D4 (1982-2001), U5 (2216-2235), D5 (2598-2617) and 
D6 (1586-1605). All primers were purchased from Genosys Biotechnol- 
ogies (The Woodlands, TX). 
2.3. PCR and subcloning of PCR products 
Genomic DNA was prepared from heparin-anticoagulated v nous 
blood samples using a QIAamp blood kit (Qiagen, Chatsworth, CA). 
Amplification of each fragment was performed using a MiniCycler 
(model PTC-150, MJ Research, Watertown, MA). Approximately 200 
ng genomic DNA was added to the PCR mixture (50 ,ul), which com- 
prised 20 mM Tris-HC1 (pH 8.4), 50 mM KC1, 1.5 mM MgC12, 0.5% 
(w/v) glycerol, 0.01 mM dithiothreitol, 0.2 mM each deoxyribonucleo- 
tide triphosphates (dATP, dGTP, dCTP, dTTP), 4/.tM each primer and 
2.5 U Taq DNA polymerase (Gibco-BRL, Gaithersburg, MD). After 
denaturation at 94°C for 3 min, amplification was carried out for 30 
cycles of denaturation at94°C for 1 min, annealing at 60°C for 1 min 
and extension at 72°C for 2 min, followed by a further 10-min extension 
at 72°C. Two partially overlapping fragments, PCR-5 and -3, in which 
entire exons II-V and VI-IX were included, were amplified using two 
pairs of primers, U1 and D6, and U4 and D5, respectively. The PCR-5 
fragment was purified by a QIAquick PCR purification kit (Qiagen) 
and subcloned irectly into a TA cloning pCR II vector (Invitrogen, 
San Diego, CA) according to the manufacturer's instructions. Twelve 
independent subclones were then selected and isolated. 
2.4. DNA sequencing analysis 
The PCR-amplified fragments were separated by 1.5% (w/v) agarose 
gel-electrophoresis and extracted with a QIAEX gel-extraction kit 
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(Qiagen). The resulting double-stranded fragments were subjected to 
direct DNA sequencing using the corresponding sequencing primers 
indicated in Fig. 1. Sequencing was carried out using a Taq DyeDeoxy 
terminator cycle sequencing kit (Applied Biosystems, Foster City, CA), 
according to the manufacturer's instructions, and the products were 
analyzed using a DNA sequencer (model 373A, Applied Biosystems). 
Direct DNA sequencing ofeach fragment was performed at least wice. 
The twelve independent PCR-5 subclones, which carried exon II with 
a sequence aberration, were separately sequenced using D 1 or universal 
-21M 13 forward primer as the sequencing primer, as described above. 
2.5. Mutation analysis with a mismatched PCR primer 
In order to confirm the mutation site, the mismatched PCR method 
[12] was used. The exon sequences including the mutation site were 
amplified with a pair of primers, the sequences of which were: 
5'-CCTGAAGATCGCAGCCTTCAACCTC-3' (sense primer M l) 
and 5"-ACCAGCCCTAGACTCCAGAG-3' (antisense primer M2). 
The sense primer was designed with a deliberate mismatch. This meant 
that the PCR product amplified from the fourth allele DNASEI*4 
would have a newly created XhoI site (CTCGAG) at the mutation site, 
whereas that from the other alleles would not contain this site. Ampli- 
fication was performed as described above, and then the 5/11 PCR 
product was digested with 40 U Xhol (New England Biolabs, MA) at 
37°C for 2 h. The digested products were subjected to 2.5% (w/v) 
Metaphore agarose (FMC BioProducts, Rockland, ME) gel-electro- 
phoresis and detected by ethidium bromide staining. 
3. Results 
A rare electrophoretic mutant (Oot-c (man)) of DNase I was 
detected in one of the urine samples collected from more than 
700 healthy Japanese individuals. The mutation was confirmed 
to have been transmitted from the subject's mother (Oot-m). 
The DNase I phenotypes of Oot-c and Oot-m were identified 
as 2-4 and 1-4, respectively, using a previously described 
method [9]. The DNase I activities in these subjects' sera were 
determined to be 4.16 + 0.78 and 3.84 + 0.10 U/l, respectively, 
and their specific activities did not differ significantly from 
those of other phenotypes 1, 1-2 and 2 [3]. 
Fragments PCR-5 and -3 were amplified individually, as a 
previous observation indicated that direct PCR amplification 
of genomic DNA would cover the majority of exonic sequences 
of the DNase I gene [6]. Since exon I contains only the non- 
coding region of mRNA,  exon I was omitted from the PCR-5 
fragment. Specific amplification of each exon using an appro- 
I II Ill IV V VI VII VIII IX 
Ul U2 U3 U4 U5 
61 [~2 D3 D6 64 1~5 
PCR-5 
PCR'3 
Sense 
UI: 5' -CTCTGAGGACATCACCATCA-3' 
U2: 5' -CTTTGTGGCGCTGTAGGGTC-3' 
U3: 5° -MGCAGGAGT(]GGGAGCTTC-3 ' 
U4: 5' - GGCTTGGGTTTTCCATTCAA-3' 
US: 5' - GTTTAGTTCCTGCGGGTGCT-3' 
Ant isense 
DI: 5' -ACCAGCCCTAGACTCCAGAG-3' 
D2: 5' -CTACTTCCCTGCTCTGTTGG-3 ' 
D3: 5' -TGGCATTCCA~TTCCCTAG-3' 
D4: 5' -AAGGCTTTGAGGCTTCTGAA-3' 
05: 5' -TTAACCCGAGTGTGTGTTGG-3' 
D6: 5' -GCCGCATG(]AGGGGAACMT-3' 
Fig. 1. (a) Schematic representation f the genomic structure of human 
DNase I [6] and the design of the primers for amplification and direct 
sequencing. Exons are shown by boxes with Roman numerals, and 
protein-coding exons are indicated by a solid box. The positions and 
direction of each primer are indicated by UI U5 and DI D6. 'U' and 
'D' denote the sense and antisense primers, respectively. Two PCR- 
amplified fragments, PCR-3 and -5, used as templates for sequencing 
analysis, are presented underneath. (b) Sequences of the primers used 
for PCR-amplification and direct sequencing. 
priate pair of PCR primers (shown in Fig. 1) demonstrated no 
difference between mutant and normal samples with regard to 
the intensity and length of the PCR-amplified fragment band 
resolved on agarose gel (data not shown). We were able to 
determine the nucleotide sequences of each exon from individ- 
uals with phenotypes 1, 2, 1-4 and 2-4. Exon II revealed only 
one heterozygous nucleotide substitution: C-to-G replacement 
occurred at position 91 in exon II (Fig. 2). The other exons of 
both the mutants were also sequenced to exclude other possibil- 
ities. The C91G mutation was found in the heterozygous state 
in the propositus. In order to confirm this substitution, the 
amplified PCR-5 fragment containing exon II from the propos- 
Phenotype 2-4 Phenotype 2 
Y Y 
A Ac ,  TONAa~oOA T 
C 
AACATC AGACAT 
G 
A AC A 1TgoC C A G A C A T 
AACATCCAGACAT 
Fig. 2. Sequencing results howing the mutation site in the propositus (Oot-c; phenotype 2-4) compared with the corresponding sequence of phenotype 
2. The PCR-amplified product, PCR-5, in which exon II was included, was subjected to direct sequencing analysis using the UI sequencing primer. 
The peaks derived from G are marked with solid black. Arrowheads how the mutation site at position 91. The nucleotides are numbered from 5' 
to 3' starting from A at the translation initiation codon. The corresponding sequences are written underneath and the nucleotide substitutions are 
underlined. The results indicate that phenotype 2-4 is heterozygous for the C-to-G transition. 
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a 
c 
CCTGAAGATCGCAGCC'n'CAACATC AGGCA 
I -°,, I 
139 bp 
M1 ' M2 
CCTGAAGATCGCAGCCTTCAACCTC 
b 
116bp 
139 bp 
1 2 3 4 5 
Fig. 3. Detection of the QgE mutation in exon II. (a) Mismatched 
amplification fgenomic DNA by PCR using a pair of primers, M 1 and 
M2. The asterisk indicates a mismatched C residue in primer M1. 
(b) Agarose gel-electrophoresis of PCR-amplified products with XhoI 
digestion. Lane 1, phenotype 1; lane 2, the mother of the propositus 
(phenotype 1~,); lane 3, the propositus (phenotype 2~,); lane 4, the 
plasmid inserted with DNASE1 *4; lane 5, the father of the propositus 
(phenotype 2). 
itus (phenotype 2-4) was subcloned, then 12 independent clones 
were selected and subjected separately to DNA sequencing: five 
clones exhibited G at position 91, whereas the rest had C, thus 
corresponding to the DNASEI*2  allele. These findings sup- 
ported the sequencing result. This mutation resulted in the 
substitution of Gln (codon CAG) by Glu (GAG) at position 9 
of the mature enzyme. We have already determined that an 
A-to-G substitution atposition 2317 and a C-to-G substitution 
at position 1592 occur in DNASEI*2  and *3 alleles, respec- 
tively [6,8]. Sequence analysis of the amplified PCR-3 fragment 
from the propositus enabled identification fG at position 2317 
(corresponding to the DNASEI*2  allele) and C at position 1592 
(corresponding to DNASEI* I  and *2 alleles). Analysis of am- 
plified fragments PCR-3 and -5 from Oot-m (phenotype 1-4) 
gave the same results as in the propositus. Thus, the nucleotide 
sequences in a coding region of the mutant were identical to 
those of phenotype 2,except for a single nucleotide at position 
91, or of phenotype 1, except for two nucleotides at positions 
91 and 2317. 
This C91G mutation neither suppressed nor created any 
known restriction enzyme recognition site in the DNase I gene. 
Therefore, we used mismatched PCR amplification followed by 
XhoI digestion to detect he missense mutation [12,13]. A 139- 
bp DNA fragment containing the mutation site was amplified 
using the primers M1 and M2 as shown in Fig. 3. If the C91G 
mutation ispresent, he mismatched nucleotide provides a new 
XhoI recognition site. This mismatched PCR-amplified product 
was therefore xpected to be degraded by XhoI to 23- and 
116-bp fragments. However, no new XhoI site is yielded if the 
DNASEI* I ,  *2 or *3 allele is present. In fact, an amplified 
product of the plasmid into which the DNASEI*4  allele was 
inserted was completely digested by XhoI to yield only a 116-bp 
fragment, whereas those derived from the other alleles were 
not. The mismatched PCR method was applied to genomic 
DNAs from the propositus and his family (Fig. 3). Both the 
amplified DNAs derived from the propositus and his mother 
had two bands (116 and 139 bp), and were therefore heterozy- 
gous for the C91G mutation. These results were consistent with 
those of the phenotyping of their enzymes by isoelectric focus- 
ing. The specificity with this method was satisfactory, and ena- 
bled us to detect he C91G mutation from samples without 
DNase I enzyme protein. 
4. Discussion 
Sequence analysis of exon II from DNase I phenotypes 1-4 
and 2-4 demonstrated that the substitution ofC by G at nucle- 
otide position 91 resulted in replacement of Gin by Glu at 
amino acid position 9 (Q9E) in the fourth allele, DNASEI*4 .  
All the nucleotide substitutions involved in the genetic poly- 
morphism of human DNase I, which is controlled by four 
alleles in the Japanese population, could be determined. The 
nucleotide/amino acid substitutions underlying the protein 
polymorphism of DNase I are summarized in Table 1. The 
results of this study demonstrated that the automated, irect 
cycle sequencing of double-stranded PCR products provides a
highly reproducible method for identification of DNA se- 
quence variations [14]. The isoenzyme ofphenotype 4 is focused 
to the IEF-PAGE gel region between those of phenotypes 1 and 
2. In comparison with phenotype 2 enzyme, the substitution of
Gln by Glu at amino acid position 9 in phenotype 4 led to a 
change in the charge state of the enzyme. The pI values of the 
phenotype 1, 2 and 4 enzymes were predicted using GENE- 
TYX-MAX (Software Development Co., Tokyo, Japan) and 
calculated to be 4.37, 4.43 and 4.40, respectively. These findings 
account for their differences in electrophoretic mobility. The 
enzymatic activities of phenotypes 2-4 and 1-4 were similar to 
those of phenotypes 1, 1-2 and 2. Furthermore, position 9may 
not be part of any putative functional site of human DNase I, 
as deduced from the bovine enzyme [16]. The amino acid resi- 
Table 1 
Nucleotide (amino acid) substitutions generating enetic polymor- 
phism of human DNase I 
Phenotype Exon II Exon VI Exon VIII 
91 (9) 1592 (132) 2317 (222) 
1 CAG (Gln) CCC (Pro) CAA (Gln) 
2 CAG (Gln) CCC (Pro) CGA (Arg) 
3 CAG (Gin) GCC (Ala) CAA (Gin) 
4 GAG (Glu) CCC (Pro) CGA (Arg) 
The nucleotide residues are numbered starting from adenine at the 
translation i itiation codon according to the previous paper [6]. The 
amino acid residues are also numbered, inparentheses, starting with the 
N-terminal residue determined in our previous tudy involving protein 
sequencing of the enzyme [15]. 
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Human 
phenotype 1 
phenotype 2 
phenotype 3 
pl~mo~rpe 4 
Bovine 
Ovlne 
Porcine 
R~ 
4 9 14 127 132 137 217 222 227 
AAFNI~TFGET 5FANPLHAAP AG M LIQ._GAWP 
AAFNIOTFGET =FAIVPLHAAP AGMURGAWP 
AAFNIOTFGET =_FANALI'IAAP AGMLIQGAWP 
AAFNIETFGET ,EFANPLHAAP ,.AGMURGAWP 
AAFNIRTFGET =_FANALHAAP AGSLLQSSWG 
AAFNIRITGET AFANPLHASP AGPLLQSSWG 
AAFNIRI-rGET EFANPLHAAP AGPLLQRAWP 
AAFNIR_TFGDT EFAIVPLHSAP : ~ AGPLLQAAWP 
Fig. 4. Comparison of the partial amino acid sequences, including the 
polymorphic (mutational) sites, between human, bovine [17], ovine [17], 
porcine [17] and rat [18] DNase I's. The amino acid residues are num- 
bered starting with the NH2-terminal residue. The amino acid residues 
responsible for the genetic polymorphism ofhuman DNase I are under- 
lined. 
due at this position is not conserved between human and other 
mammalian enzymes; the bovine, ovine, porcine [17] and rat 
[18] counterparts have Arg at the corresponding position (Fig. 
4). Therefore, it is reasonable to conclude that the amino acid 
substitution at position 9 does not affect any specific function 
of  DNase I. 
Elucidation of the mutation site in phenotype 4 allows us to 
postulate the complete molecular basis of the genesis of poly- 
morphism in human DNase I. Considering that DNASEI*I 
and *2 alleles occur at high frequencies in the Japanese popula- 
tion, and that Gln at position 222 is conserved in other mam- 
mals, it is plausible to assume that the DNASEI*I allele is an 
ancestral monomorphic gene. A point mutation in exon VIII  
of the DNASEI*I allele may have produced DNASEI*2. The 
DNASEI*3 and *4 alleles must have been generated by a point 
mutation in exon VI of DNASEI*I and one in exon II of 
DNASEI *2, respectively. 
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